Cardinal Health, Inc. (NYSE:CAH) Given Average Recommendation of “Hold” by Analysts

by · The Cerbat Gem

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) has been given a consensus recommendation of “Hold” by the nine ratings firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $96.83.

A number of analysts recently weighed in on CAH shares. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $101.00 to $112.00 and gave the stock a “neutral” rating in a report on Friday, November 17th. TheStreet raised shares of Cardinal Health from a “c” rating to a “b-” rating in a report on Tuesday, November 14th. Evercore ISI decreased their target price on shares of Cardinal Health from $100.00 to $95.00 in a report on Wednesday, October 11th. StockNews.com started coverage on shares of Cardinal Health in a report on Thursday, October 5th. They set a “strong-buy” rating on the stock. Finally, Mizuho increased their price target on shares of Cardinal Health from $94.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, August 16th.

View Our Latest Stock Report on CAH

Cardinal Health Trading Up 1.7 %

Shares of CAH stock opened at $107.08 on Friday. The stock has a market capitalization of $26.39 billion, a P/E ratio of 175.54, a PEG ratio of 1.01 and a beta of 0.76. The firm’s 50 day moving average is $96.24 and its 200 day moving average is $91.81. Cardinal Health has a 12 month low of $68.53 and a 12 month high of $107.16.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Friday, November 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.33. The business had revenue of $54.76 billion for the quarter, compared to analyst estimates of $54.85 billion. Cardinal Health had a net margin of 0.07% and a negative return on equity of 60.27%. Cardinal Health’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.20 EPS. On average, equities analysts predict that Cardinal Health will post 6.89 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd will be paid a $0.5006 dividend. The ex-dividend date is Friday, December 29th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.87%. Cardinal Health’s dividend payout ratio (DPR) is 327.87%.

Insider Activity

In other news, CEO Deborah Weitzman sold 36,642 shares of the company’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $106.31, for a total value of $3,895,411.02. Following the completion of the sale, the chief executive officer now owns 35,202 shares of the company’s stock, valued at approximately $3,742,324.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.15% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cardinal Health

Institutional investors have recently made changes to their positions in the business. Gradient Investments LLC boosted its position in Cardinal Health by 106.7% during the 2nd quarter. Gradient Investments LLC now owns 277 shares of the company’s stock valued at $26,000 after buying an additional 143 shares during the period. Cornerstone Planning Group LLC purchased a new stake in Cardinal Health during the 3rd quarter valued at $26,000. Covestor Ltd boosted its position in Cardinal Health by 59.8% during the 2nd quarter. Covestor Ltd now owns 294 shares of the company’s stock valued at $28,000 after buying an additional 110 shares during the period. Stonebridge Capital Advisors LLC purchased a new stake in Cardinal Health during the 2nd quarter valued at $29,000. Finally, Global Trust Asset Management LLC purchased a new stake in Cardinal Health during the 2nd quarter valued at $31,000. Hedge funds and other institutional investors own 86.01% of the company’s stock.

Cardinal Health Company Profile

(Get Free Report

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading